Search for: "Fed Ex"
Results 1241 - 1260
of 2,366
Sort by Relevance
|
Sort by Date
31 Jan 2013, 8:41 am
See also In re Harris, 409 F.3d 1339, 1341 (Fed. [read post]
31 Jan 2013, 8:33 am
In re Oetiker, 977 F.2d 1443, 1445 (Fed. [read post]
30 Jan 2013, 9:14 pm
Mahurkar, 935 F.2d 1555, 1563 (Fed. [read post]
30 Jan 2013, 9:05 pm
From Ex parte BeydaAppellant lost on double-patenting. [read post]
30 Jan 2013, 9:01 pm
(In re Huang, 100 F.3d 135, 139- 40 (Fed. [read post]
30 Jan 2013, 8:46 pm
Iqbal, 556 U.S.662, 678 (2009) and of Rule 9(b), Fed. [read post]
28 Jan 2013, 4:18 am
On January 11, in U.S. ex rel. [read post]
25 Jan 2013, 4:01 pm
In re Applied Materials, Inc., 692 F.3d 1289, 1297 (Fed. [read post]
25 Jan 2013, 11:48 am
., 543 F.3d 665 (Fed. [read post]
23 Jan 2013, 4:16 pm
Appx. 959 (Fed. [read post]
23 Jan 2013, 12:10 pm
Patent and Trademark Office on issued final rules setting revised patent fees under Section 10 of the America Invents Act. (78 Fed. [read post]
23 Jan 2013, 1:02 am
” Denial, 76 Fed. [read post]
23 Jan 2013, 1:02 am
” Denial, 76 Fed. [read post]
22 Jan 2013, 4:10 am
In re Viterra Inc.., 101 U.S.P.Q.2d 1905 (Fed. [read post]
18 Jan 2013, 7:33 am
See Ex parte Nehls, 88 USPQ2d 1883, 1887-88 (BPAI 2008) (precedential).3 It follows that Appellants have not shown error in the Examiner’s rejection of claim 1 as being anticipated by Erdogan.ANDSee also Ex parte Mathias, 84 USPQ2d 1276, 1279 (BPAI 2005) (informative), aff’d 191 Fed. [read post]
18 Jan 2013, 7:28 am
from Ex part SHEPHERDOf written description:Ariad Pharms., Inc. v. [read post]
18 Jan 2013, 7:22 am
See In re Gulack, 703 F.2d 1381, 1386 (Fed. [read post]
18 Jan 2013, 7:01 am
Inc., 800 F.2d 1091, 1097 (Fed. [read post]
17 Jan 2013, 2:15 pm
See In re Schreiber, 128 F.3d 1473, 1478 (Fed. [read post]
17 Jan 2013, 4:30 am
Patent 5,499,017 in ex parte patent reexamination. [read post]
